Frontiers in Cancer Research

癌症研究前沿

• 批准号: 10645418
• 负责人: Jeanne Ting Chowning
• 金额: $ 11.12万
• 依托单位: FRED HUTCHINSON CANCER CENTER
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-08-01 至 2023-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10645418
• 关键词: Frontiers; Cancer; Research

PROJECT SUMMARY/ABSTRACT Frontiers in Cancer Research (“Frontiers”) is presented by the Science Education Partnership (SEP) at Fred Hutchinson Cancer Research Center (“Fred Hutch”). The Frontiers program is designed to meet two goals of the National Institutes of Health (NIH) and National Institute of General Medical Sciences (NIGMS): to increase the STEM content knowledge and pedagogical skills of teachers and to engage students, especially those from underserved populations, in basic and clinical medical research. Overall, Frontiers aims to increase public understanding of basic molecular and cellular biology, how this knowledge informs research questions, and how clinical research translates into cancer therapies and cures. More specifically, Frontiers focuses on exciting new NIH-funded research at Fred Hutch, such as immunotherapy, that promises to fundamentally change cancer treatment. The program will also explore the ethical implications of cancer research-related topics. Another goal is to introduce students, particularly those from backgrounds underrepresented in the biomedical sciences, to career possibilities in research. 1) Frontiers will engage secondary school students in basic molecular/cellular biology and cutting-edge cancer research by creating, piloting, and disseminating two Next Generation Science Standards (NGSS)-aligned cancer-focused curricular units (Project Violet: Anti-Cancer Molecules, Cancer Immunotherapy) and three different types of hands-on scientific kits (Protein Modeling and Cancer Treatment, Bioengineering Plasmid Design, and CRISPR/Cas9). The units, which will consist of 5-7 lessons to span 2-3 weeks, will also help students examine ethical issues related to genetic engineering, gene therapy, and clinical trials. We will use small randomized controlled trials to evaluate the efficacy of the developed curricular materials. 2) Frontiers will enhance the ability of secondary school life science teachers to teach fundamental biological principles and practices through the lens of cancer research by providing 20 teachers annually (Y2-Y5) with a 3-week summer professional development program that includes a mentored research experience, and 7 day- long sessions throughout the school year. 3) Frontiers aims to inspire secondary school students from underrepresented communities to pursue biomedical and clinical research careers. Our introductory school-year outreach program will bring 270 students annually to Fred Hutch to meet scientists and participate in Frontiers lessons held in dedicated Fred Hutch student training labs. We will also create and implement a model for scientists at Fred Hutch to visit classrooms to assist teachers with lessons and share their career paths with students.

项目总结/摘要 癌症研究前沿（“前沿”）由弗雷德·安德森的科学教育伙伴关系（SEP）提出。 哈钦森癌症研究中心（“弗雷德·哈奇”）。Frontiers计划旨在实现两个目标， 美国国立卫生研究院（NIH）和国家普通医学科学研究所（NIGMS）：增加 教师的STEM内容知识和教学技能，并让学生，特别是来自 在基础和临床医学研究中，总体而言，Frontiers旨在增加公众 了解基本的分子和细胞生物学，这些知识如何告知研究问题，以及 临床研究如何转化为癌症治疗和治愈。更具体地说，前沿侧重于 弗雷德·哈奇（Fred Hutch）资助的令人兴奋的新研究，如免疫疗法，有望从根本上 改变癌症治疗。该计划还将探讨与癌症研究有关的伦理问题。 话题另一个目标是介绍学生，特别是那些来自背景不足的学生， 生物医学科学，研究的职业机会。 1)前沿将使中学生参与基础分子/细胞生物学和尖端癌症 通过创建，试点和传播两个下一代科学标准（NGSS）进行研究， 以癌症为重点的课程单位（项目紫：抗癌分子，癌症免疫疗法）和三个 不同类型的动手科学工具包（蛋白质建模和癌症治疗，生物工程质粒 设计和CRISPR/Cas9）。这些单元将包括5-7节课，跨度2-3周，也将有所帮助。 学生研究与基因工程、基因治疗和临床试验有关的伦理问题。我们将使用 小型随机对照试验，以评估开发的课程材料的有效性。 2)前沿将提高中学生命科学教师教授基础生物学的能力 通过癌症研究的透镜，向20名教师提供每年（Y2-Y 5）的 3-一周的夏季专业发展计划，包括指导研究经验，和7天- 整个学年的长时间课程。 3)Frontiers旨在激励来自代表性不足社区的中学生追求 生物医学和临床研究事业。我们的介绍性学年外展计划将带来270 学生每年到弗雷德哈奇，以满足科学家，并参加在专门弗雷德举行的前沿课程 哈奇学生训练实验室。我们还将创建和实施一个模型，供弗雷德哈奇的科学家访问 教室，以协助教师的经验教训，并分享他们的职业道路与学生。